PolyPid Ltd. business relationships
Companies named in PolyPid Ltd.’s 20-F filed 2026-02-25, and public companies whose annual reports name PolyPid Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 70 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Layers: GLP-1 & obesity
Named in PolyPid Ltd.’s annual report 2
“connection with our existing collaboration with ADVANZ PHARMA Corp., or Advanz, as well as those that we may enter into in the future” SEC filing
“a new research and development collaboration with ImmunoGenesis, Inc., or ImmunoGenesis, a Houston-based clinical-stage biotechnology” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.